Decapolis Systems v. Steward Health Care: Case Dismissed After 99 Days
Decapolis Systems, LLC asserted two healthcare information-processing patents against Steward Health Care Network, Inc. and Steward Health Care System, LLC in the Eastern District of Texas. The case was dismissed just 99 days after filing, before reaching substantive motion practice.
A Fast-Closing Healthcare IT Patent Dispute in E.D. Texas
On 18 October 2022, Decapolis Systems, LLC filed a patent infringement complaint against Steward Health Care Network, Inc. and Steward Health Care System, LLC in the Eastern District of Texas (Case No. 2:22-cv-00407). The suit asserted two patents — US7490048B2 and US7464040B2 — covering apparatus and methods for processing and providing healthcare information, a technology domain that spans clinical data management and health information exchange platforms.
The recorded basis of termination is 'Case Dismissed.' The docket order states that, pursuant to Rule 41(a)(1)(A)(ii), all pending claims and causes of action are dismissed without prejudice. A Rule 41(a)(1)(A)(ii) dismissal is a stipulated dismissal signed by all parties, and the court's order reflects acceptance of that stipulation. The specific terms agreed between the parties are not disclosed in the available public record.
Resolution in 99 days — before any substantive rulings — is notably swift even for cases that settle early. The speed suggests the parties may have reached an accommodation quickly after the complaint was filed, though what drove that resolution cannot be confirmed from the public record. Because the dismissal is without prejudice, Decapolis Systems retains the ability to refile claims on these patents, which is a meaningful consideration for Steward and any similarly situated health network.
See Complete Case & Patent Analysis →Filing to Case Dismissed in 99 days
99 days — resolved well short of the typical E.D. Texas patent litigation timeline
US7490048B2 & US7464040B2 — Healthcare Information Processing
Health networks, EHR vendors, health information exchange operators, and clinical data platform developers should treat these two patents as live freedom-to-operate considerations. Neither has been invalidated or subjected to claim construction in this proceeding. If your product or platform processes, stores, or delivers healthcare information, an FTO analysis against both patents is advisable — particularly before entering contracts with hospital systems or health insurers.
Official order — verbatim text
The docket order accepts a stipulation under Rule 41(a)(1)(A)(ii) and dismisses all pending claims without prejudice. No liability finding, claim construction ruling, or damages assessment was entered. The without-prejudice qualifier is legally significant: it preserves Decapolis Systems' right to refile, and Steward obtains no preclusive defence from this order.
Case dismissed: what the without-prejudice ruling means for both parties
Rule 41(a)(1)(A)(ii): a stipulated, party-driven dismissal
A Rule 41(a)(1)(A)(ii) dismissal requires agreement of all parties and takes effect without a court order on the merits. The court's role is to accept and acknowledge the stipulation — it does not adjudicate liability. This mechanism ends the current proceeding but leaves the underlying patent claims legally unresolved.
No merits adjudicationWithout prejudice: refiling remains open
A dismissal without prejudice does not bar Decapolis Systems from bringing the same patent claims against Steward — or other defendants — in a future action. Steward obtains no preclusive judgment here. For defendants in the health IT sector, this means the litigation risk from US7490048B2 and US7464040B2 is not extinguished by this dismissal.
Refiling risk remainsDecapolis retains enforcement options on both patents
Because no invalidity ruling, claim construction, or damages determination was entered, both asserted patents emerge from this proceeding with their enforceability intact. Decapolis Systems can pursue enforcement against Steward entities or third parties. The absence of a covenant not to sue or any disclosed settlement terms means future exposure cannot be ruled out from publicly available information.
Patents remain enforceableHealth networks face unresolved patent exposure in healthcare IT
Health information processing platforms remain an active target for patent assertion. A without-prejudice dismissal in E.D. Texas does not create industry-wide clearance. Competing health networks and EHR vendors operating in overlapping technology spaces should consider whether their systems fall within the scope of US7490048B2 or US7464040B2, particularly given the patents' broad apparatus-and-method framing.
Sector-wide risk unresolvedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Decapolis Systems, LLC | Company | Healthcare IT patent assertion entity — holder of US7490048B2 and US7464040B2Search in Eureka ↗ |
| Defendant | Steward Health Care Network, Inc. | Company | Steward Health Care Network, Inc. and Steward Health Care System, LLC — integrated health networkSearch in Eureka ↗ |
| Co-Defendant | Steward Health Care System, LLC | Company | Search in Eureka ↗ |
| Plaintiff counsel | Randall T. Garteiser | Attorney | Counsel for Decapolis Systems, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Decapolis Systems, LLCSearch in Eureka ↗ |
| Defendant counsel | Charles E. Phipps | Attorney | Counsel for Steward Health Care Network, Inc.Search in Eureka ↗ |
| Defendant law firm | Locke Lord LLP | Law Firm | Representing Steward Health Care Network, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
R&D signals in the healthcare information processing patent space
Forward-looking patent intelligence on Decapolis Systems' portfolio, the health IT filing landscape, Steward Health Care's IP posture, and adjacent white-space opportunities near the asserted patents.
Decapolis Systems' healthcare IT patent cluster
Decapolis Systems holds at least two foundational healthcare information processing patents (US7490048B2, US7464040B2) with early-2000s application dates. Monitoring their full portfolio reveals whether additional apparatus or method claims — potentially covering adjacent health data workflows — could support further assertions against health networks or EHR vendors.
Portfolio monitoring priorityPatent filing trends in health information exchange and EHR
The healthcare information processing space has seen sustained patent filing activity as EHR interoperability, clinical decision support, and patient data exchange have matured. Tracking filing trends around apparatus-and-method claims for healthcare data processing helps product teams anticipate where assertion risk is densest and where design-around space exists.
High filing-density domainSteward Health Care's patent and technology position
Large integrated health networks like Steward typically operate as technology consumers rather than patent holders, making them recurring targets for assertion in the health IT space. Assessing Steward's technology stack and any defensive IP holdings helps gauge how other similarly sized health networks might respond to comparable patent demands.
Health network IP defenceAdjacent innovation near early healthcare data processing patents
Patents filed in the early 2000s on healthcare information apparatus leave substantial white space in downstream areas: real-time clinical analytics, AI-assisted triage, interoperability APIs, and patient-facing data portals. Companies building in these adjacent areas should map claim boundaries of foundational patents like US7490048B2 to identify protectable innovation corridors.
Adjacent filing opportunitySimilar healthcare IT patent infringement cases in E.D. Texas
Explore comparable patent assertion cases involving healthcare information processing patents filed in the Eastern District of Texas, including early dismissals and consent judgments.
What this case signals for the healthcare IT IP landscape
A rapid without-prejudice dismissal in E.D. Texas leaves both asserted patents legally viable — and the enforcement story unfinished.
Without-prejudice outcomes demand ongoing patent monitoring
When a case ends without prejudice, the asserted patents do not lose enforceability. Health networks, EHR vendors, and clinical data platform providers should actively monitor US7490048B2 and US7464040B2 for subsequent assertions or licensing activity, particularly given Decapolis's continued ownership.
E.D. Texas remains a favoured venue for health IT patent assertions
The Eastern District of Texas continues to attract patent infringement filings in software-adjacent healthcare technology. Even fast-resolved cases signal the jurisdiction's appeal for assertion entities. In-house teams at health networks should maintain jurisdiction-aware risk registers for this court.
Decapolis v Steward — key questions answered
Decapolis Systems asserted US7490048B2 (application 09/987226) and US7464040B2 (application 09/737348), both covering apparatus and methods for processing and providing healthcare information. The case was filed in the Eastern District of Texas on 18 October 2022.
The docket order dismisses all pending claims without prejudice pursuant to Rule 41(a)(1)(A)(ii). The recorded basis of termination is 'Case Dismissed.' A without-prejudice dismissal means Decapolis Systems is not barred from refiling claims based on the same patents against Steward or other defendants.
A Rule 41(a)(1)(A)(ii) dismissal is a stipulated dismissal signed by all parties. It carries no merits adjudication — no invalidity finding, no claim construction, and no damages determination. Both US7490048B2 and US7464040B2 remain enforceable patents after this proceeding.
Yes. Because the dismissal is without prejudice, Decapolis Systems retains the right to refile claims based on US7490048B2 and US7464040B2 against Steward Health Care or other defendants. Steward receives no preclusive defence from this order. The specific terms agreed between the parties, if any, are not disclosed in the available public record.
The case closed 99 days after filing, which is notably fast for E.D. Texas patent litigation. The stipulated dismissal under Rule 41(a)(1)(A)(ii) suggests the parties reached an accommodation without court intervention, but the specific terms are not disclosed in the available public record. No substantive rulings were issued before dismissal.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.